CNBC September 20, 2023
Stefan Sykes

Key Points

– Tobacco giant Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.

– The company has been making inroads into the wellness and health-care space in recent years as it pivots toward becoming a business focused on smoke-free products and respiratory medicines.

– More recently, the division has struggled, and Philip Morris has had talks with Deutsche Bank on a range of options to try to grow its wellness and health-care division.

Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.

The tobacco company, which makes Marlboro cigarettes, made inroads into the health care and wellness space in 2021 with the acquisition of Vectura, a U.K.-based pharmaceutical company...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Provider, Trends, Wellness
From weight to wellness: New database could transform obesity research
5 Wellness Trends That Might Be Secretly Harming You—By A Psychologist
How Global Healthcare Systems are Integrating Mental Health and Wellness Services
A comparison of wellness practices across continents
Wearable Tech Is Changing Fitness—Here's How Studios Can Keep Up

Share This Article